Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Envestnet Portfolio Solutions Inc. increased its stake in shares of argenx SE (NASDAQ:ARGX – Free Report) by 7.9% in the 4th quarter, Holdings Channel reports. The firm owned 1,509 shares of the ...

"All three types of myasthenia gravis, based on antibody status ... In LRP4 disease, "false positives can be seen with motor neuron disease," he said. "I recommend always having neurophysiological ...

Farther Finance Advisors LLC grew its stake in shares of argenx SE (NASDAQ:ARGX – Free Report) by 38.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 76 shares ...

anticipated by YE’24 Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results anticipated in 2H’25 Phase 2 MoMeNtum trial of DNTH103 in Multifocal Motor ...

Weakness in the legs can be due to a spine or leg injury, but other potential causes can include diabetic neuropathy, cancer, stroke, myasthenia gravis, and other underlying conditions. It is a common ...

This week we are going to discuss a topic that we had briefly touched on earlier, the neurologic autoimmune conditions: myasthenia gravis and Lambert Eaton Syndrome (LEMS). To review: Myasthenia ...

Kingfisher, the owner of leading DIY brands such as B&Q, Screwfix and Castorama, will unveil its full-year results on Tuesday ...

to $61 from $58 and keeps a Buy rating on the shares following yesterday’s topline data from the Batoclimab Myasthtenia Gravis and chronic inflammatory demyelinating polyneuropathy studies.

qMRI is a key tool for analyzing the structure and composition of skeletal muscle and finding subtle pathological changes, and in muscular dystrophies, such measures are linked with motor function ...